AZN stock · GSK stock · Lician Pro · $19.99/mo or $149/yr · These side-by-side numbers as JSON? API free 100/day

AZN vs GSK · $288.38B cap vs $103.31B cap

AstraZeneca PLC (AZN) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.

AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.

GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.

AZN does not have a complete income-statement cache yet.

GSK does not have a complete income-statement cache yet.

AZN currently screens at market cap $288.38B. GSK currently screens at market cap $103.31B.

Not investment advice. Open the AZN and GSK stock pages for the full models.

Basic comparison

Price, market cap, and trailing P/E stay on this page.

AZN vs GSK
MetricAZNGSK
Price$171.49$50.75
Market cap$288.38B$103.31B
Trailing P/E——

Deeper peer metrics

Net income and multi-year revenue growth are the peek. More peer metrics open below. This block stops at the labels.

More peer metrics

Operating margin, EPS, free cash flow, and gross margin are on Pro.

Unlock deeper peer metrics

These side-by-side numbers as JSON? API free 100/day

AZN vs GSK comparison FAQ

What is AZN's market cap?

AstraZeneca PLC (AZN) currently screens at market cap $288.38B.

What is GSK's market cap?

GlaxoSmithKline PLC ADR (GSK) currently screens at market cap $103.31B.

How many AZN vs GSK comparison scalars are listed on this page?

This page lists 2 cached comparison scalars for AZN vs GSK: AZN market cap and GSK market cap.

Where is the AZN vs GSK comparison listed?

The cached AZN vs GSK comparison is listed at https://lician.com/compare/azn-vs-gsk.

Not investment advice.

Popular Stock Comparisons